| |
| |
|
| Insider
Information: |
Lebuhn Robert |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
43,985 |
|
|
Indirect Shares
|
1,000 |
|
|
| Direct
Value |
$110,816 |
|
|
|
Indirect Value
|
$59,940 |
|
|
| Total
Shares |
44,985 |
|
|
| Total
Value |
$170,756 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cambrex Corp |
CBM |
Director |
2005-04-26 |
1,796 |
2005-02-25 |
1,000 |
Premium* |
|
|
Enzon Pharmaceuticals Inc |
ENZN |
Director |
2013-09-19 |
42,189 |
2004-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2013-09-19 |
4 |
S |
$1.69 |
$35,626 |
D/D |
(21,119) |
42,189 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2013-09-17 |
4 |
S |
$1.74 |
$60,456 |
D/D |
(34,807) |
63,308 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2012-08-14 |
4 |
S |
$6.58 |
$38,308 |
D/D |
(5,820) |
98,115 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2012-08-10 |
4 |
S |
$6.58 |
$12,720 |
D/D |
(1,933) |
103,935 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,669 |
105,868 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2011-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,382 |
95,199 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2011-06-01 |
4 |
S |
$10.57 |
$91,980 |
D/D |
(8,702) |
0 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2011-02-22 |
4 |
S |
$10.88 |
$108,817 |
D/D |
(10,000) |
96,519 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2010-08-26 |
4 |
S |
$10.49 |
$104,929 |
D/D |
(10,000) |
106,519 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2010-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,173 |
116,519 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,043 |
113,346 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2008-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,105 |
102,024 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2008-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,172 |
100,919 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
97,747 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,417 |
96,492 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2007-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,105 |
86,075 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2007-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
84,970 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2007-01-02 |
4 |
OE |
$2.94 |
$117,500 |
D/D |
40,000 |
83,715 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2006-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,255 |
43,715 |
|
- |
|
| CBM |
Cambrex Corp |
Director |
– • – |
2005-04-26 |
4/A |
OE |
$11.44 |
$17,156 |
D/D |
1,500 |
1,796 |
|
- |
|
| CBM |
Cambrex Corp |
Director |
– • – |
2005-04-26 |
4 |
OE |
$11.44 |
$17,156 |
D/D |
1,500 |
17,000 |
|
- |
|
| CBM |
Cambrex Corp |
Director |
– • – |
2005-02-25 |
4 |
S |
$22.00 |
$24,200 |
I/I |
(1,100) |
1,000 |
|
- |
|
| CBM |
Cambrex Corp |
Director |
– • – |
2005-02-22 |
4 |
S |
$22.27 |
$20,095 |
I/I |
(900) |
2,100 |
|
- |
|
| CBM |
Cambrex Corp |
Director |
– • – |
2004-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
296 |
|
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2004-07-19 |
4 |
OE |
$2.75 |
$73,326 |
D/D |
26,664 |
42,460 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
